Ashton Thomas Private Wealth, LLC Gilead Sciences, Inc. Transaction History
Ashton Thomas Private Wealth, LLC
- $3.86 Trillion
- Q3 2025
A detailed history of Ashton Thomas Private Wealth, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 57,976 shares of GILD stock, worth $7.19 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
57,976
Previous 47,869
21.11%
Holding current value
$7.19 Million
Previous $5.31 Billion
21.26%
% of portfolio
0.17%
Previous 0.19%
Shares
19 transactions
Others Institutions Holding GILD
# of Institutions
2,374Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...